EurekAlert!

ECOG-ACRIN discovers a simple blood test may predict recurrence of breast cancer

A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict high or low risk of a breast cancer relapse. This is according to data presented today at ...
ascopubs.org

Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing tumor genetic testing: Results from the ECOG-ACRIN NCI Community ...

The BRCA founder outreach study: Initial results of a digital health model. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text component.
EurekAlert!

ECOG-ACRIN and Caris Life Sciences partner to interrogate landmark TAILORx breast cancer trial

ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Caris Life Sciences ® (Caris) announced today a multi-year research collaboration wherein Caris is pairing its highly sophisticated and comprehensive ...
PharmiWeb

Foundation Medicine Announces Expanded Participation in National Cancer Institute’s ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker ...

Foundation Medicine remains one of the chief contributors to ComboMATCH, the largest of its kind initiative to test effectiveness of biomarker-targeted cancer treatment combinations BOSTON--(BUSINESS ...